Trifluoromethanesulfonic Acid

Trifluoromethanesulfonic Acid

SCHEMBL548465

C[N+](C)(C)C.O=S(=O)(O)C(F)(F)F

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
CA1 P00915 2/20 0.37
CA2 P00918 2/20 0.37
CA7 P43166 1/20 0.37
CA13 Q8N1Q1 1/20 0.37
TSHR P16473 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
F2 P00734 2/20 0.32
PRSS1 P07477 2/20 0.32
PRSS2 P07478 2/20 0.32
PRSS3 P35030 2/20 0.32
CA5A P35218 1/20 0.31
CA5B Q9Y2D0 1/20 0.31
EPHX1 P07099 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoromethanesulfonic Acid SCHEMBL4825075 0.89 ALDH1A1 (0.47) ALDH1A1L3MBTL1CA1CA2CA7
Trifluoromethanesulfonic Acid SCHEMBL8067232 0.89 ALDH1A1 (0.47) ALDH1A1L3MBTL1CA1CA2CA7
Trifluoromethanesulfonic Acid SCHEMBL8054873 0.89 ALDH1A1 (0.47) ALDH1A1L3MBTL1CA1CA2CA7
Trifluoromethanesulfonic Acid SCHEMBL8068862 0.89 ALDH1A1 (0.47) ALDH1A1L3MBTL1CA1CA2CA7
Trifluoromethanesulfonic Acid SCHEMBL3968739 0.89
Trifluoromethanesulfonic Acid SCHEMBL8066536 0.89 ALDH1A1 (0.47) ALDH1A1L3MBTL1CA1CA2CA7
Trifluoromethanesulfonic Acid SCHEMBL8065122 0.89 ALDH1A1 (0.47) ALDH1A1L3MBTL1CA1CA2CA7
Trifluoromethanesulfonic Acid SCHEMBL8071267 0.89 ALDH1A1 (0.47) ALDH1A1L3MBTL1CA1CA2CA7
Trifluoromethanesulfonic Acid SCHEMBL8055527 0.89 ALDH1A1 (0.47) ALDH1A1L3MBTL1CA1CA2CA7
Trifluoromethanesulfonic Acid SCHEMBL8054999 0.89 ALDH1A1 (0.47) ALDH1A1L3MBTL1CA1CA2CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 364 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115418181-A Antistatic silica gel protection film 惠州市浩明科技股份有限公司 2022-12-02 CN claimed
CN-104098078-B Activation MCMB, its preparation method and ultracapacitor 中国科学院长春应用化学研究所 2016-09-28 CN claimed
US-6699621-B2 ELECTROPOLYMERIZING MONOMERS ON TO A SUBSTRATE IN A POLYMERIZATION SOLUTION; ELECTROCHEMICALLY CONDITIONING POLYMER SO AS TO INCREASE DISCHARGE EFFICIENCY AND CHARGE CAPACITY; DOPING TO IMPART A NON-NEUTRAL CHARGE JOHNS HOPKINS UNIVERSITY 2004-03-02 US claimed
US-20260146026-A1 COMPOUND, COMPOSITION, CURED PRODUCT, METHOD FOR PRODUCING CURED PRODUCT, AND METHOD FOR PRODUCING ELECTRONIC COMPONENT ADEKA CORPORATION (JP) 2026-05-28 US disclosed
US-20260118767-A1 REVERSE PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2026-04-30 US disclosed
EP-4700067-A1 COMPOSITION FOR FORMING SILICON-CONTAINING FILM, METHOD FOR FORMING FILM, AND SUPERSTRATE SHIN-ETSU CHEMICAL CO., LTD. (JP) 2026-02-25 EP disclosed
US-20260044081-A1 COMPOSITION FOR FORMING SILICON-CONTAINING RESIST FILM AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2026-02-12 US disclosed
EP-4692941-A2 COMPOSITION FOR FORMING SILICON-CONTAINING RESIST FILM AND PATTERNING PROCESS Shin-Etsu Chemical Co., Ltd. (JP) 2026-02-11 EP disclosed
US-20260029706-A1 COMPOSITION FOR FORMING SILICON-CONTAINING FILM, METHOD FOR FORMING FILM, AND SUPER STRAIGHT SHIN-ETSU CHEMICAL CO., LTD. (JP) 2026-01-29 US disclosed
US-20260008932-A1 COMPOSITION FOR FORMING RESIST UNDERLAYER FILM, PATTERNING PROCESS, AND RESIST UNDERLAYER FILM FORMATION PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2026-01-08 US disclosed
EP-4675357-A1 COMPOSITION FOR FORMING RESIST UNDERLAYER FILM, PATTERNING PROCESS, AND RESIST UNDERLAYER FILM FORMATION PROCESS Shin-Etsu Chemical Co., Ltd. (JP) 2026-01-07 EP disclosed
WO-1998019355-A1 AN ELECTROCHEMICAL STORAGE CELL CONTAINING AT LEAST ONE ELECTRODE FORMULATED FROM A FLUOROPHENYL THIOPHENE POLYMER THE JOHNS-HOPKINS UNIVERSITY (US) 1998-05-07 WO disclosed
US-5733683-A ELECTROCONDUCTIVE POLYMER OF FLUOROPHENYL POLYTHIOPHENE FOR ELECTROLYTIC CELLS THE JOHNS HOPKINS UNIVERSITY (US) 1998-03-31 US disclosed
US-5728796-A Process to react epoxide-containing compounds and aliphatic alcohols THE DOW CHEMICAL COMPANY (US) 1998-03-17 US disclosed
CN-1174854-A Electrolyte and electrolytic cell ROHM & HAAS (US) 1998-03-04 CN disclosed
EP-0821368-A2 Electrolyte and electrolytic cell ROHM AND HAAS COMPANY (US) 1998-01-28 EP disclosed
CN-1138338-A Method for reacting epoxide-containing compounds with aliphatic alcohols DOW CHEMICAL CO (US) 1996-12-18 CN disclosed
EP-0736052-A1 PROCESS TO REACT EPOXIDE-CONTAINING COMPOUNDS AND ALIPHATIC ALCOHOLS THE DOW CHEMICAL COMPANY (US) 1996-10-09 EP disclosed
US-5527640-A DOPABLE POLYTHIOPHENES; TETRAALKYLAMMONIUM SALTS AS ELECTROLYTE THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, OFFICE OF TECHNOLOGY TRANSFER (US) 1996-06-18 US disclosed
WO-1995017445-A1 PROCESS TO REACT EPOXIDE-CONTAINING COMPOUNDS AND ALIPHATIC ALCOHOLS THE DOW CHEMICAL COMPANY (US) 1995-06-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260008932-A1 COMPOSITION FOR FORMING RESIST UNDERLAYER FILM, PATTERNING PROCESS, AND RESIST UNDERLAYER FILM FORMATION PROCESS ASH2L, ALKBH2, ITGA1 ALDH1A1 841/4885L3MBTL1 1216/4885CA1 29/4885
US-20260146026-A1 COMPOUND, COMPOSITION, CURED PRODUCT, METHOD FOR PRODUCING CURED PRODUCT, AND METHOD FOR PRODUCING ELECTRONIC COMPONENT CBR3, CBR1, NOTUM ALDH1A1 827/4885L3MBTL1 2247/4885CA1 467/4885
US-20260029706-A1 COMPOSITION FOR FORMING SILICON-CONTAINING FILM, METHOD FOR FORMING FILM, AND SUPER STRAIGHT SMC2, F12, SMC1A ALDH1A1 1644/4885L3MBTL1 2207/4885CA1 297/4885
US-20260118767-A1 REVERSE PATTERNING PROCESS EFNA1, EPHA4, ETV6 ALDH1A1 4452/4885L3MBTL1 1596/4885CA1 1449/4885
US-20260044081-A1 COMPOSITION FOR FORMING SILICON-CONTAINING RESIST FILM AND PATTERNING PROCESS SMC1A, SPOUT1, LBR ALDH1A1 1558/4885L3MBTL1 282/4885CA1 964/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.